Phase II trial of the novel oral Akt inhibitor perifosine in relapsed and/or refractory Waldenstrom macroglobulinemia (WM)

8546 Background: Perifosine is an oral, synthetic alkylphospholipid, with multiple effects including inhibition of Akt. We previously showed that perifosine induces significant growth inhibition in...